Lysyl oxidase-like 4 (LOXL4) promotes proliferation and metastasis of gastric cancer via FAK/Src pathway - PubMed (original) (raw)

. 2015 Feb;141(2):269-81.

doi: 10.1007/s00432-014-1823-z. Epub 2014 Sep 14.

Wen-yi Zhao, Fang Fang, Chun Zhuang, Xiao-xin Zhang, Xiao-mei Yang, Shu-heng Jiang, Fan-zhi Kong, Lin Tu, Wen-ming Zhang, Sheng-li Yang, Hui Cao, Zhi-gang Zhang

Affiliations

Lysyl oxidase-like 4 (LOXL4) promotes proliferation and metastasis of gastric cancer via FAK/Src pathway

Rong-kun Li et al. J Cancer Res Clin Oncol. 2015 Feb.

Abstract

Background: Lysyl oxidase-like 4 (LOXL4) has been found up-regulated in a variety of human malignancies, but its clinical significance and functional roles in gastric cancer (GC) remain unknown.

Methods: Lysyl oxidase-like 4 (LOXL4) expression level in tumor tissues and human GC cell lines was evaluated by quantitative real-time polymerase chain reaction, Western blotting and immunohistochemical analyses. Its clinical significance was inferred from the analysis of 379 tissue samples of patients with GC using tissue microarray. The roles of LOXL4 in cell proliferation, migration and invasion in vitro were analyzed by gene over-expression, RNA interference and recombinant protein. Effects of LOXL4 on regulation of focal adhesion kinase/Src kinase (FAK/Src) pathway were examined by Western blotting.

Results: Lysyl oxidase-like 4 (LOXL4) was up-regulated in GC tissues relative to paired non-tumor tissues, and this over-expression was significantly associated with tumor size, depth of tumor invasion, lymph node metastasis, tumor-node-metastasis (TNM) stages and poorer overall survival. Over-expression of LOXL4 has promotive effects on GC cell proliferation, migration and invasion in vitro, consistent with this, LOXL4 knockdown has inhibitive effects on GC cell proliferation, migration and invasion. Furthermore, recombinant human LOXL4 protein also promoted GC cell proliferation and migration. Subsequent mechanistic studies showed that LOXL4 could activate FAK/Src pathway to enhance cell-extracellular matrix adhesion.

Conclusions: Taken together, our data reveal that up-regulation of LOXL4 expression is a frequent event in GC progression, contributes to tumor cell proliferation and metastasis, and LOXL4 may be a potential independent prognostic marker and therapeutic target for GC.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cancer Res. 2005 Dec 15;65(24):11429-36 - PubMed
    1. Mol Cell Biol. 1998 May;18(5):2571-85 - PubMed
    1. J Hepatol. 2014 Jun;60(6):1225-34 - PubMed
    1. Oncogene. 1999 Nov 18;18(48):6824-8 - PubMed
    1. Cancer Res. 2007 May 1;67(9):4123-9 - PubMed

MeSH terms

Substances

LinkOut - more resources